EGM
LAB icon

Engineers Gate Manager’s Standard BioTools LAB Stock Holding History

Engineers Gate Manager’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.5K Buy
+68,665
New +$64.9K ﹤0.01% 2126
2024
Q2 		– Sell
-45,383
Closed -$123K – 2105
2024
Q1 		$123K Buy
45,383
+31,016
+216% +$74.9K ﹤0.01% 1718
2023
Q4 		$31.8K Sell
14,367
-1,971
-12% -$4.21K ﹤0.01% 1880
2023
Q3 		$47.4K Sell
16,338
-1,154
-7% -$3.02K ﹤0.01% 1658
2023
Q2 		$33.8K Buy
17,492
+3,202
+22% +$6.32K ﹤0.01% 1645
2023
Q1 		$27.9K Buy
14,290
+43
+0.3% +$85 ﹤0.01% 1578
2022
Q4 		$16.7K Sell
14,247
-3,103
-18% -$3.82K ﹤0.01% 1609
2022
Q3 		$19K Sell
17,350
-44,909
-72% -$67.9K ﹤0.01% 1538
2022
Q2 		$100K Buy
+62,259
New +$154K ﹤0.01% 1734
2021
Q3 		– Sell
-30,208
Closed -$186K – 1811
2021
Q2 		$186K Sell
30,208
-81,992
-73% -$438K 0.01% 1422
2021
Q1 		$507K Buy
112,200
+100,900
+893% +$554K 0.03% 986
2020
Q4 		$68K Sell
11,300
-2,300
-17% -$15.1K ﹤0.01% 1618
2020
Q3 		$101K Buy
+13,600
New +$93.9K ﹤0.01% 1556
2020
Q2 		– Sell
-41,970
Closed -$107K – 1851
2020
Q1 		$107K Sell
41,970
-152,823
-78% -$502K 0.01% 1403
2019
Q4 		$678K Buy
194,793
+19,526
+11% +$68.7K 0.03% 832
2019
Q3 		$811K Buy
175,267
+40,962
+30% +$323K 0.04% 601
2019
Q2 		$1.66M Buy
134,305
+23,132
+21% +$295K 0.09% 367
2019
Q1 		$1.48M Buy
111,173
+56,704
+104% +$598K 0.09% 334
2018
Q4 		$470K Buy
54,469
+23,761
+77% +$185K 0.04% 542
2018
Q3 		$230K Buy
30,708
+4,518
+17% +$32.1K 0.02% 704
2018
Q2 		$156K Buy
26,190
+4,340
+20% +$24.7K 0.01% 895
2018
Q1 		$128K Buy
+21,850
New +$143K 0.01% 756
2016
Q3 		– Sell
-17,877
Closed -$161K – 685
2016
Q2 		$161K Sell
17,877
-16,505
-48% -$155K 0.01% 635
2016
Q1 		$277K Buy
+34,382
New +$248K 0.02% 578

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Engineers Gate Manager's LAB Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Standard BioTools (LAB) in Q2 2026: 68,665 shares worth $56.5K. The stake represents ﹤0.01% of the portfolio and ranks #2126 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in LAB as recently as Q1 2024.

Engineers Gate Manager first reported a position in LAB in Q1 2016 and has held it in 24 quarters since. The position peaked at $1.66M in Q2 2019. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Engineers Gate Manager held 68,665 shares of Standard BioTools worth $56.5K as of Q2 2026.
  • Standard BioTools was a new Engineers Gate Manager position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2126 holding.
  • Engineers Gate Manager first reported a position in Standard BioTools in Q1 2016 and has held it in 24 quarters since.
  • Engineers Gate Manager's Standard BioTools position peaked at $1.66M in Q2 2019.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.